Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 3Sanofi-Aventis Canada Inc.
01 31329203
01 3Dolasetron Mesylate
01 1Injection
02 2Tablet
01 32011-05-03
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2011-05-03
Date Granted : 1994-05-03
Brand Name : ANZEMET
Patent Number : 1329203
Filing Date : 1987-10-29
Strength per Unit : 50 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2011-05-03
Date Granted : 1994-05-03
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2011-05-03
Date Granted : 1994-05-03
Brand Name : ANZEMET
Patent Number : 1329203
Filing Date : 1987-10-29
Strength per Unit : 100 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2011-05-03
Date Granted : 1994-05-03
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2011-05-03
Date Granted : 1994-05-03
Brand Name : ANZEMET
Patent Number : 1329203
Filing Date : 1987-10-29
Strength per Unit : 20 mg/ml
Dosage Form : Injection
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2011-05-03
Date Granted : 1994-05-03
LOOKING FOR A SUPPLIER?